NRX Pharmaceuticals's total assets for Q3 2024 were $4.46M, a decrease of -15.24% from the previous quarter. NRXP total liabilities were $23.28M for the fiscal quarter, a -1.57% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.